Roth Capital Downgrades Arcturus Therapeutics (ARCT) to Sell
Tweet Send to a Friend
Roth Capital analyst Elemer Piros downgraded Arcturus Therapeutics (NASDAQ: ARCT) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
